search
PRM Pharma
Trends
- 1PRM Pharma and Ingenus Win Orange Book Patent Listing for HemiClor●PRM Pharma and Ingenus Pharmaceuticals Announce Orange Book Listing of Patent Protecting HemiClor® Formulation Technology
PRM Pharma and Ingenus Pharmaceuticals announced that a patent covering the formulation technology behind HemiClor has been listed in the FDA's Orange Book, the register of approved drugs and related patents. The listing strengthens intellectual property protection for the chlorhexidine-based formulation. Details on the patent's scope or the companies' next steps were not immediately available beyond the joint announcement.